|
|
interleukin 6 production
|
GO:0032635 |
37 |
1.000
|
Human |
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
44 |
1.000
|
Human |
|
|
cellular response to bacterial lipoprotein
|
GO:0071220 |
3 |
1.000
|
|
|
|
negative regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903556 |
20 |
1.000
|
Human |
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.999
|
|
|
|
negative regulation of tumor necrosis factor production
|
GO:0032720 |
20 |
0.999
|
Human |
|
|
activation of innate immune response
|
GO:0002218 |
55 |
0.999
|
Human |
|
|
innate immune response activating signal transduction
|
GO:0002758 |
48 |
0.999
|
Human |
|
|
toll like receptor 2 signaling pathway
|
GO:0034134 |
4 |
0.998
|
Human |
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.996
|
Human |
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.996
|
Human Mouse |
|
|
negative regulation of interleukin 6 production
|
GO:0032715 |
13 |
0.995
|
Human |
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
51 |
0.995
|
|
|
|
positive regulation of toll like receptor 4 signaling pathway
|
GO:0034145 |
6 |
0.995
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.995
|
Human |
|
|
cytokine production
|
GO:0001816 |
247 |
0.994
|
Human |
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
43 |
0.994
|
Human |
|
|
response to peptidoglycan
|
GO:0032494 |
3 |
0.994
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
57 |
0.994
|
Human Mouse |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.993
|
Human |
|
|
cellular response to biotic stimulus
|
GO:0071216 |
71 |
0.993
|
Human Mouse |
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.993
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
48 |
0.992
|
Human |
|
|
positive regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031666 |
4 |
0.992
|
|
|
|
growth of symbiont in host
|
GO:0044117 |
1 |
0.992
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
62 |
0.988
|
Human Mouse |
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.986
|
|
|
|
positive regulation of toll like receptor signaling pathway
|
GO:0034123 |
10 |
0.984
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
45 |
0.983
|
Human |
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.979
|
Human |
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
26 |
0.978
|
Human Mouse |
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
1 |
0.975
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.974
|
Human |
|
|
response to bacterium
|
GO:0009617 |
144 |
0.974
|
Human Mouse |
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.973
|
Human Mouse |
|
|
response to lipoteichoic acid
|
GO:0070391 |
3 |
0.973
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.970
|
Human |
|
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.967
|
Human Mouse |
|
|
positive regulation of nik nf kappab signaling
|
GO:1901224 |
10 |
0.966
|
Human |
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.965
|
Human |
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.964
|
Human |
|
|
regulation of nik nf kappab signaling
|
GO:1901222 |
11 |
0.964
|
Human |
|
|
regulation of interleukin 6 production
|
GO:0032675 |
37 |
0.962
|
Human |
|
|
toll like receptor signaling pathway
|
GO:0002224 |
25 |
0.961
|
Human |
|
|
response to other organism
|
GO:0051707 |
261 |
0.961
|
Human Mouse |
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.958
|
Human |
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
9 |
0.958
|
Human |
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.951
|
Human |
|
|
tumor necrosis factor production
|
GO:0032640 |
43 |
0.950
|
Human |
|
|
positive regulation of interleukin 23 production
|
GO:0032747 |
4 |
0.950
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.949
|
Human |
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.944
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.943
|
Human |
|
|
interleukin 1 mediated signaling pathway
|
GO:0070498 |
12 |
0.940
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.934
|
Human |
|
|
positive regulation of toll like receptor 2 signaling pathway
|
GO:0034137 |
2 |
0.922
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.917
|
Human Mouse |
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.916
|
Human |
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.915
|
Human Mouse |
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
17 |
0.910
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.905
|
Human Mouse |
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.904
|
Human |
|
|
chemokine biosynthetic process
|
GO:0042033 |
4 |
0.903
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.901
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
2 |
0.900
|
|
|
|
regulation of interleukin 12 production
|
GO:0032655 |
15 |
0.899
|
Human |
|
|
growth involved in symbiotic interaction
|
GO:0044110 |
2 |
0.897
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.887
|
Human |
|
|
positive regulation of toll like receptor 3 signaling pathway
|
GO:0034141 |
1 |
0.879
|
|
|
|
growth of symbiont involved in interaction with host
|
GO:0044116 |
2 |
0.876
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.876
|
Human |
|
|
activation of immune response
|
GO:0002253 |
114 |
0.874
|
Human |
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.873
|
|
|
|
response to interleukin 1
|
GO:0070555 |
47 |
0.868
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.859
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.849
|
Human |
|
|
negative regulation of macrophage cytokine production
|
GO:0010936 |
3 |
0.846
|
|
|
|
chemokine metabolic process
|
GO:0050755 |
4 |
0.840
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.829
|
Human Mouse |
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.817
|
Human |
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.816
|
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
20 |
0.814
|
Human |
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.813
|
Human Mouse |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.813
|
Human |
|
|
antifungal humoral response
|
GO:0019732 |
2 |
0.811
|
|
|
|
regulation of interleukin 17 production
|
GO:0032660 |
12 |
0.804
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.802
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.797
|
Human |
|
|
defense response
|
GO:0006952 |
315 |
0.797
|
Human |
|
|
interleukin 17 production
|
GO:0032620 |
12 |
0.788
|
|
|
|
regulation of toll like receptor 2 signaling pathway
|
GO:0034135 |
2 |
0.785
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.780
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
11 |
0.778
|
|
|
|
regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031664 |
13 |
0.777
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.774
|
Human |
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.764
|
|
|
|
regulation of chemokine biosynthetic process
|
GO:0045073 |
4 |
0.761
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.752
|
Human |
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.740
|
Human |
|
|
positive regulation of chemokine production
|
GO:0032722 |
22 |
0.723
|
|
|
|
smooth muscle cell proliferation
|
GO:0048659 |
28 |
0.709
|
|
|
|
positive regulation of stress activated protein kinase signaling cascade
|
GO:0070304 |
61 |
0.704
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
25 |
0.700
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
80 |
0.700
|
|
|
|
response to bacterial lipoprotein
|
GO:0032493 |
3 |
0.694
|
|
|
|
positive regulation of chemokine biosynthetic process
|
GO:0045080 |
3 |
0.691
|
|
|
|
toll like receptor 4 signaling pathway
|
GO:0034142 |
12 |
0.690
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
23 |
0.689
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.685
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.684
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
23 |
0.677
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.676
|
Human |
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
46 |
0.642
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.639
|
Human |
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
8 |
0.638
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.624
|
|
|
|
response to diacyl bacterial lipopeptide
|
GO:0071724 |
2 |
0.591
|
|
|
|
negative regulation of interleukin 12 production
|
GO:0032695 |
6 |
0.590
|
Human |
|
|
immune response
|
GO:0006955 |
307 |
0.586
|
Human |
|
|
organic hydroxy compound transport
|
GO:0015850 |
63 |
0.568
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.554
|
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
20 |
0.545
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.542
|
|
|
|
regulation of nitric oxide biosynthetic process
|
GO:0045428 |
17 |
0.540
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.519
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
56 |
0.511
|
Human |
|
|
jnk cascade
|
GO:0007254 |
80 |
0.509
|
|
|
|
cellular response to bacterial lipopeptide
|
GO:0071221 |
3 |
0.497
|
|
|
|
positive regulation of smooth muscle cell proliferation
|
GO:0048661 |
14 |
0.495
|
|
|
|
negative regulation of cholesterol efflux
|
GO:0090370 |
2 |
0.494
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
41 |
0.492
|
|
|
|
detection of diacyl bacterial lipopeptide
|
GO:0042496 |
2 |
0.476
|
|
|
|
i kappab phosphorylation
|
GO:0007252 |
7 |
0.472
|
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
22 |
0.462
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.460
|
Human |
|
|
positive regulation of jnk cascade
|
GO:0046330 |
52 |
0.458
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.457
|
|
|
|
cholesterol efflux
|
GO:0033344 |
28 |
0.456
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.442
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
2 |
0.440
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.440
|
|
|
|
regulation of smooth muscle cell proliferation
|
GO:0048660 |
28 |
0.436
|
|
|
|
macrophage cytokine production
|
GO:0010934 |
4 |
0.428
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
27 |
0.427
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.424
|
Human |
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.402
|
Human |
|
|
immune effector process
|
GO:0002252 |
159 |
0.402
|
|
|
|
positive regulation of interferon alpha biosynthetic process
|
GO:0045356 |
4 |
0.397
|
|
|
|
interleukin 12 production
|
GO:0032615 |
15 |
0.385
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.380
|
|
|
|
fat cell differentiation
|
GO:0045444 |
32 |
0.380
|
|
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.375
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.370
|
Human |
|
|
detection of bacterial lipoprotein
|
GO:0042494 |
3 |
0.363
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
84 |
0.360
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
60 |
0.359
|
Human |
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.358
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
59 |
0.354
|
Human |
|
|
production of molecular mediator of immune response
|
GO:0002440 |
37 |
0.352
|
|
|
|
cellular response to uv
|
GO:0034644 |
32 |
0.350
|
|
|
|
type i interferon biosynthetic process
|
GO:0045351 |
4 |
0.350
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.341
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.339
|
Human |
|
|
negative regulation of nitric oxide biosynthetic process
|
GO:0045019 |
5 |
0.332
|
|
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
85 |
0.325
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.320
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
60 |
0.319
|
|
|
|
positive regulation of protein binding
|
GO:0032092 |
24 |
0.318
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.314
|
Human |
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.310
|
|
|
|
negative regulation of cytokine production involved in immune response
|
GO:0002719 |
13 |
0.305
|
|
|
|
negative regulation of cytokine mediated signaling pathway
|
GO:0001960 |
22 |
0.303
|
|
|
|
response to triacyl bacterial lipopeptide
|
GO:0071725 |
2 |
0.300
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.291
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.290
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
73 |
0.290
|
|
|
|
response to fungus
|
GO:0009620 |
4 |
0.286
|
|
|
|
regulation of autophagy
|
GO:0010506 |
52 |
0.279
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.271
|
Human |
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.269
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.266
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.266
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.263
|
Human |
|
|
regulation of growth
|
GO:0040008 |
165 |
0.262
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.256
|
Human |
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.248
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.244
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.243
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
93 |
0.242
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.241
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.239
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.239
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.239
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.236
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
48 |
0.232
|
|
|
|
lipid transport
|
GO:0006869 |
90 |
0.232
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.231
|
Human |
|
|
autophagy
|
GO:0006914 |
88 |
0.228
|
|
|
|
positive regulation of interferon beta biosynthetic process
|
GO:0045359 |
4 |
0.228
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.217
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.217
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.217
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.215
|
|
|
|
type i interferon production
|
GO:0032606 |
27 |
0.213
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
22 |
0.213
|
|
|
|
rna stabilization
|
GO:0043489 |
18 |
0.213
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.209
|
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
21 |
0.204
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
36 |
0.200
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
22 |
0.198
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
73 |
0.197
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.187
|
Human |
|
|
interferon alpha biosynthetic process
|
GO:0045349 |
4 |
0.186
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.185
|
|
|
|
cellular response to diacyl bacterial lipopeptide
|
GO:0071726 |
2 |
0.184
|
|
|
|
positive regulation of autophagy
|
GO:0010508 |
24 |
0.182
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.182
|
Human |
|
|
nucleotide binding oligomerization domain containing signaling pathway
|
GO:0070423 |
4 |
0.182
|
|
|
|
positive regulation of mononuclear cell proliferation
|
GO:0032946 |
47 |
0.177
|
|
|
|
immunoglobulin secretion
|
GO:0048305 |
1 |
0.175
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.173
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.173
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
27 |
0.170
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
48 |
0.170
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.166
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
29 |
0.163
|
|
|
|
defense response to fungus
|
GO:0050832 |
4 |
0.162
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.162
|
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.160
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.157
|
Human |
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.156
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.156
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.152
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
35 |
0.149
|
|
|
|
lipid storage
|
GO:0019915 |
28 |
0.147
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.146
|
Human |
|
|
epithelium development
|
GO:0060429 |
227 |
0.145
|
|
|
|
regulation of rna stability
|
GO:0043487 |
23 |
0.143
|
|
|
|
cholesterol transport
|
GO:0030301 |
39 |
0.142
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.142
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.140
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.139
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.139
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.132
|
|
|
|
protein complex disassembly
|
GO:0043241 |
52 |
0.131
|
Human |
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.130
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.127
|
|
|
|
positive regulation of interleukin 6 biosynthetic process
|
GO:0045410 |
1 |
0.127
|
|
|
|
cellular response to triacyl bacterial lipopeptide
|
GO:0071727 |
2 |
0.127
|
|
|
|
positive regulation of humoral immune response
|
GO:0002922 |
3 |
0.124
|
|
|
|
growth
|
GO:0040007 |
202 |
0.124
|
|
|
|
chemokine production
|
GO:0032602 |
32 |
0.123
|
|
|
|
myeloid leukocyte cytokine production
|
GO:0061082 |
5 |
0.123
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.121
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.120
|
Human |
|
|
regulation of tolerance induction
|
GO:0002643 |
4 |
0.120
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.114
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.113
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
92 |
0.112
|
|
|
|
regulation of lipid storage
|
GO:0010883 |
21 |
0.109
|
|
|
|
response to heat
|
GO:0009408 |
21 |
0.107
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.106
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.105
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.105
|
|
|
|
detection of bacterial lipopeptide
|
GO:0070340 |
3 |
0.105
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
119 |
0.103
|
Human |
|
|
inflammatory response
|
GO:0006954 |
79 |
0.102
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.102
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.102
|
Human |
|
|
positive regulation of interleukin 17 production
|
GO:0032740 |
8 |
0.101
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.100
|
|
|
|
regulation of chemokine c x c motif ligand 2 production
|
GO:2000341 |
2 |
0.100
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.099
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.099
|
|
|
|
negative regulation of immune response
|
GO:0050777 |
40 |
0.098
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.097
|
|
|
|
mrna stabilization
|
GO:0048255 |
18 |
0.097
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
46 |
0.097
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.097
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
57 |
0.097
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.097
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.096
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.094
|
|
|
|
cellular response to heat
|
GO:0034605 |
14 |
0.094
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.093
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.092
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
25 |
0.091
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
37 |
0.089
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
27 |
0.087
|
Human |
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.087
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.087
|
|
|
|
regulation of macrophage cytokine production
|
GO:0010935 |
4 |
0.087
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.086
|
Human |
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.085
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.085
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.084
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.083
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.082
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.082
|
|
|
|
regulation of interferon alpha biosynthetic process
|
GO:0045354 |
4 |
0.082
|
|
|
|
negative regulation of production of molecular mediator of immune response
|
GO:0002701 |
13 |
0.080
|
|
|
|
nik nf kappab signaling
|
GO:0038061 |
12 |
0.077
|
Human |
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.077
|
Human |
|
|
response to bacterial lipopeptide
|
GO:0070339 |
3 |
0.076
|
|
|
|
positive regulation of t cell cytokine production
|
GO:0002726 |
4 |
0.076
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.075
|
|
|
|
toll like receptor 3 signaling pathway
|
GO:0034138 |
4 |
0.073
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.073
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.072
|
|
|
|
sterol transport
|
GO:0015918 |
39 |
0.072
|
|
|
|
cellular response to lipoteichoic acid
|
GO:0071223 |
3 |
0.071
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
44 |
0.071
|
|
|
|
nf kappab import into nucleus
|
GO:0042348 |
22 |
0.070
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.070
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
38 |
0.070
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.070
|
|
|
|
regulation of toll like receptor 3 signaling pathway
|
GO:0034139 |
2 |
0.070
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.069
|
|
|
|
positive regulation of interleukin 8 biosynthetic process
|
GO:0045416 |
8 |
0.068
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.068
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
4 |
0.068
|
|
|
|
positive regulation of nf kappab import into nucleus
|
GO:0042346 |
13 |
0.067
|
|
|
|
regulation of protein homodimerization activity
|
GO:0043496 |
9 |
0.067
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.067
|
|
|
|
negative regulation of growth of symbiont in host
|
GO:0044130 |
1 |
0.066
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.065
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.065
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.064
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.064
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.064
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
34 |
0.064
|
|
|
|
negative regulation of tumor necrosis factor mediated signaling pathway
|
GO:0010804 |
7 |
0.062
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
47 |
0.061
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
21 |
0.060
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.059
|
|
|
|
interleukin 1 production
|
GO:0032612 |
26 |
0.058
|
|
|
|
3 utr mediated mrna stabilization
|
GO:0070935 |
8 |
0.058
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.058
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
74 |
0.058
|
|
|
|
negative regulation of toll signaling pathway
|
GO:0045751 |
1 |
0.056
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.056
|
Human |
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
35 |
0.055
|
|
|
|
regulation of interleukin 2 production
|
GO:0032663 |
19 |
0.055
|
|
|
|
regulation of interleukin 6 biosynthetic process
|
GO:0045408 |
5 |
0.055
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
34 |
0.054
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.054
|
|
|
|
detection of triacyl bacterial lipopeptide
|
GO:0042495 |
2 |
0.054
|
|
|
|
positive regulation of granulocyte chemotaxis
|
GO:0071624 |
9 |
0.053
|
|
|
|
positive regulation of b cell proliferation
|
GO:0030890 |
12 |
0.053
|
|
|
|
nucleotide binding oligomerization domain containing 2 signaling pathway
|
GO:0070431 |
4 |
0.053
|
|
|
|
positive regulation of cytokine mediated signaling pathway
|
GO:0001961 |
12 |
0.053
|
|
|
|
positive regulation of interleukin 1 production
|
GO:0032732 |
14 |
0.053
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.053
|
|
|
|
antimicrobial humoral response
|
GO:0019730 |
26 |
0.053
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.052
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.051
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.051
|
|
|
|
interleukin 6 biosynthetic process
|
GO:0042226 |
5 |
0.051
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.050
|
|
|
|
b cell activation
|
GO:0042113 |
33 |
0.049
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.049
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.049
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
4 |
0.049
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.048
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.048
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.047
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.046
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.046
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.046
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.046
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.044
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.044
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.044
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
15 |
0.044
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
21 |
0.043
|
|
|
|
regulation of alkaline phosphatase activity
|
GO:0010692 |
2 |
0.043
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
54 |
0.042
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
31 |
0.042
|
|
|
|
myeloid dendritic cell differentiation
|
GO:0043011 |
3 |
0.042
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.041
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.041
|
|
|
|
regulation of tumor necrosis factor mediated signaling pathway
|
GO:0010803 |
12 |
0.041
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.041
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.041
|
|
|
|
regulation of interleukin 1 mediated signaling pathway
|
GO:2000659 |
3 |
0.041
|
|
|
|
positive regulation of antimicrobial humoral response
|
GO:0002760 |
1 |
0.040
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.040
|
|
|
|
establishment of endothelial barrier
|
GO:0061028 |
16 |
0.040
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.039
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
9 |
0.039
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.039
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.038
|
|
|
|
tumor necrosis factor mediated signaling pathway
|
GO:0033209 |
27 |
0.038
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.038
|
|
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.038
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.037
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.037
|
|
|
|
t helper 1 type immune response
|
GO:0042088 |
8 |
0.037
|
|
|
|
interleukin 8 production
|
GO:0032637 |
51 |
0.036
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.036
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.036
|
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
11 |
0.035
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.035
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
46 |
0.034
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.034
|
|
|
|
negative regulation of toll like receptor 3 signaling pathway
|
GO:0034140 |
2 |
0.034
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.034
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
11 |
0.032
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.032
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
1 |
0.032
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.032
|
|
|
|
response to exogenous dsrna
|
GO:0043330 |
10 |
0.031
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
22 |
0.031
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.031
|
|
|
|
positive regulation of neutrophil migration
|
GO:1902624 |
7 |
0.030
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
63 |
0.030
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.030
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
99 |
0.030
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.029
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.029
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.029
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.029
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.029
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.029
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.029
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.028
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.028
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.028
|
|
|
|
regulation of type i interferon mediated signaling pathway
|
GO:0060338 |
9 |
0.028
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.028
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.027
|
|
|
|
cellular response to interleukin 1
|
GO:0071347 |
35 |
0.027
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.027
|
|
|
|
endothelial cell development
|
GO:0001885 |
18 |
0.027
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.026
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.026
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.025
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.025
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.025
|
|
|
|
negative regulation of smooth muscle cell proliferation
|
GO:0048662 |
14 |
0.025
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.025
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
24 |
0.025
|
|
|
|
regulation of cholesterol efflux
|
GO:0010874 |
11 |
0.025
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
33 |
0.024
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.024
|
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.024
|
Human |
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.024
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.024
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.024
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
39 |
0.024
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.024
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.024
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
17 |
0.023
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
22 |
0.023
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.023
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.023
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.022
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.022
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
18 |
0.022
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.022
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.022
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.022
|
|
|
|
positive regulation of type i interferon mediated signaling pathway
|
GO:0060340 |
4 |
0.022
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.022
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.022
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.022
|
|
|
|
regulation of mitosis
|
GO:0007088 |
63 |
0.022
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.022
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.022
|
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.021
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.021
|
|
|
|
positive regulation of protein homodimerization activity
|
GO:0090073 |
5 |
0.021
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
76 |
0.021
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
21 |
0.021
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.021
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.021
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.021
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.021
|
|
|
|
positive regulation of leukocyte migration
|
GO:0002687 |
46 |
0.021
|
|
|
|
regulation of interleukin 10 production
|
GO:0032653 |
16 |
0.021
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.021
|
|
|
|
positive regulation of monocyte chemotactic protein 1 production
|
GO:0071639 |
3 |
0.020
|
|
|
|
interleukin 2 production
|
GO:0032623 |
20 |
0.020
|
|
